Alan [SBDC advisor] had been a banker his whole career. He had worldly experience in banking and a quick understanding of manufacturing. This made him very easy to relate to and work with.
Vice President of Business Development, Washington Equipment Manufacturing Company
Alan [SBDC advisor] had been a banker his whole career. He had worldly experience in banking and a quick understanding of manufacturing. This made him very easy to relate to and work with.
Vice President of Business Development, Washington Equipment Manufacturing Company
Alan [SBDC advisor] had been a banker his whole career. He had worldly experience in banking and a quick understanding of manufacturing. This made him very easy to relate to and work with.
Vice President of Business Development, Washington Equipment Manufacturing Company
Alan [SBDC advisor] had been a banker his whole career. He had worldly experience in banking and a quick understanding of manufacturing. This made him very easy to relate to and work with.
Vice President of Business Development, Washington Equipment Manufacturing Company
Alan [SBDC advisor] had been a banker his whole career. He had worldly experience in banking and a quick understanding of manufacturing. This made him very easy to relate to and work with.
Vice President of Business Development, Washington Equipment Manufacturing Company
ExesaLibero Pharma Innovates New Rheumatoid Arthritis Treatment
ExesaLibero Pharma has completed preclinical studies on a drug designed to control excess bone erosion associated with rheumatoid arthritis and multiple myeloma. It will also be effective against trauma-induced arthritis. The company received an Innovation Award at the 2022 TechConnect DC Conference. A Phase II STTR bolstered development from the National Institutes of Health, which was reinforced by a matching fund from the State of West Virginia through the WV SBDC. "Matching funds are extremely important to SBIR/STTR grantees, providing essential bridge funds to get from research to commercialization," said Dr. John Barnett, President and Chief Science Officer.
ExesaLibero Pharma Innovates New Rheumatoid Arthritis Treatment
ExesaLibero Pharma has completed preclinical studies on a drug designed to control excess bone erosion associated with rheumatoid arthritis and multiple myeloma. It will also be effective against trauma-induced arthritis. The company received an Innovation Award at the 2022 TechConnect DC Conference. A Phase II STTR bolstered development from the National Institutes of Health, which was reinforced by a matching fund from the State of West Virginia through the WV SBDC. "Matching funds are extremely important to SBIR/STTR grantees, providing essential bridge funds to get from research to commercialization," said Dr. John Barnett, President and Chief Science Officer.
ExesaLibero Pharma Innovates New Rheumatoid Arthritis Treatment
ExesaLibero Pharma has completed preclinical studies on a drug designed to control excess bone erosion associated with rheumatoid arthritis and multiple myeloma. It will also be effective against trauma-induced arthritis. The company received an Innovation Award at the 2022 TechConnect DC Conference. A Phase II STTR bolstered development from the National Institutes of Health, which was reinforced by a matching fund from the State of West Virginia through the WV SBDC. "Matching funds are extremely important to SBIR/STTR grantees, providing essential bridge funds to get from research to commercialization," said Dr. John Barnett, President and Chief Science Officer.
ExesaLibero Pharma Innovates New Rheumatoid Arthritis Treatment
ExesaLibero Pharma has completed preclinical studies on a drug designed to control excess bone erosion associated with rheumatoid arthritis and multiple myeloma. It will also be effective against trauma-induced arthritis. The company received an Innovation Award at the 2022 TechConnect DC Conference. A Phase II STTR bolstered development from the National Institutes of Health, which was reinforced by a matching fund from the State of West Virginia through the WV SBDC. "Matching funds are extremely important to SBIR/STTR grantees, providing essential bridge funds to get from research to commercialization," said Dr. John Barnett, President and Chief Science Officer.
ExesaLibero Pharma Innovates New Rheumatoid Arthritis Treatment
ExesaLibero Pharma has completed preclinical studies on a drug designed to control excess bone erosion associated with rheumatoid arthritis and multiple myeloma. It will also be effective against trauma-induced arthritis. The company received an Innovation Award at the 2022 TechConnect DC Conference. A Phase II STTR bolstered development from the National Institutes of Health, which was reinforced by a matching fund from the State of West Virginia through the WV SBDC. "Matching funds are extremely important to SBIR/STTR grantees, providing essential bridge funds to get from research to commercialization," said Dr. John Barnett, President and Chief Science Officer.
Rapid Radicals connects to people who want to see them succeed!
You need support to help you succeed! Creating partnerships that your small business can lean on is incredibly important. Please find out more from someone who knows who wants to be part of her journey and how Wisconsin makes innovation possible.
Rapid Radicals connects to people who want to see them succeed!
You need support to help you succeed! Creating partnerships that your small business can lean on is incredibly important. Please find out more from someone who knows who wants to be part of her journey and how Wisconsin makes innovation possible.
Rapid Radicals connects to people who want to see them succeed!
You need support to help you succeed! Creating partnerships that your small business can lean on is incredibly important. Please find out more from someone who knows who wants to be part of her journey and how Wisconsin makes innovation possible.
Rapid Radicals connects to people who want to see them succeed!
You need support to help you succeed! Creating partnerships that your small business can lean on is incredibly important. Please find out more from someone who knows who wants to be part of her journey and how Wisconsin makes innovation possible.
Rapid Radicals connects to people who want to see them succeed!
You need support to help you succeed! Creating partnerships that your small business can lean on is incredibly important. Please find out more from someone who knows who wants to be part of her journey and how Wisconsin makes innovation possible.
Women-Owned Small Business, Wyonics, Receives $1.2 Million Department of Energy Phase II Grant
Wyonics LLC, a women-owned business in Laramie, Wyoming, was selected to receive a nearly $1.2 million Small Business Innovation Research (SBIR) Phase II award from the U.S. Department of Energy (DOE) to further the development and commercialization of instrumentation platforms for the non-destructive manipulation and analysis of micro- and nano-sized materials. “While these awards are selected based on technical merit and commercial potential, we are particularly proud to be one of the few women-owned small businesses receiving funding in this round,” said Dr. Kristin Di Bona, CEO, and Co-Founder of Wyonics LLC. Wyonics is the first women-owned small business in Wyoming to receive a DOE SBIR award.
Women-Owned Small Business, Wyonics, Receives $1.2 Million Department of Energy Phase II Grant
Wyonics LLC, a women-owned business in Laramie, Wyoming, was selected to receive a nearly $1.2 million Small Business Innovation Research (SBIR) Phase II award from the U.S. Department of Energy (DOE) to further the development and commercialization of instrumentation platforms for the non-destructive manipulation and analysis of micro- and nano-sized materials. “While these awards are selected based on technical merit and commercial potential, we are particularly proud to be one of the few women-owned small businesses receiving funding in this round,” said Dr. Kristin Di Bona, CEO, and Co-Founder of Wyonics LLC. Wyonics is the first women-owned small business in Wyoming to receive a DOE SBIR award.
Women-Owned Small Business, Wyonics, Receives $1.2 Million Department of Energy Phase II Grant
Wyonics LLC, a women-owned business in Laramie, Wyoming, was selected to receive a nearly $1.2 million Small Business Innovation Research (SBIR) Phase II award from the U.S. Department of Energy (DOE) to further the development and commercialization of instrumentation platforms for the non-destructive manipulation and analysis of micro- and nano-sized materials. “While these awards are selected based on technical merit and commercial potential, we are particularly proud to be one of the few women-owned small businesses receiving funding in this round,” said Dr. Kristin Di Bona, CEO, and Co-Founder of Wyonics LLC. Wyonics is the first women-owned small business in Wyoming to receive a DOE SBIR award.
Women-Owned Small Business, Wyonics, Receives $1.2 Million Department of Energy Phase II Grant
Wyonics LLC, a women-owned business in Laramie, Wyoming, was selected to receive a nearly $1.2 million Small Business Innovation Research (SBIR) Phase II award from the U.S. Department of Energy (DOE) to further the development and commercialization of instrumentation platforms for the non-destructive manipulation and analysis of micro- and nano-sized materials. “While these awards are selected based on technical merit and commercial potential, we are particularly proud to be one of the few women-owned small businesses receiving funding in this round,” said Dr. Kristin Di Bona, CEO, and Co-Founder of Wyonics LLC. Wyonics is the first women-owned small business in Wyoming to receive a DOE SBIR award.
Women-Owned Small Business, Wyonics, Receives $1.2 Million Department of Energy Phase II Grant
Wyonics LLC, a women-owned business in Laramie, Wyoming, was selected to receive a nearly $1.2 million Small Business Innovation Research (SBIR) Phase II award from the U.S. Department of Energy (DOE) to further the development and commercialization of instrumentation platforms for the non-destructive manipulation and analysis of micro- and nano-sized materials. “While these awards are selected based on technical merit and commercial potential, we are particularly proud to be one of the few women-owned small businesses receiving funding in this round,” said Dr. Kristin Di Bona, CEO, and Co-Founder of Wyonics LLC. Wyonics is the first women-owned small business in Wyoming to receive a DOE SBIR award.